Assess Safety and Compare PK of New Oral hPTH(1-34) Tablet Formulations vs. EBP05 Tablets and Subcutaneous Forteo

Condition:   Hypoparathyroidism Interventions:   Drug: EBP05;   Drug: Forteo 20 mg;   Drug: EBP11;   Drug: EBP22;   Drug: EBP11-M Sponsor:   Entera Bio Ltd. Recruiting

Source: ClinicalTrials.gov - July 28, 2023 Category: Research Source Type: clinical trials